Yu Mizutani
Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Steroid responsive rapidly progressive HTLV-1-associated myelopathy with HTLV-1-associated bronchioloalveolar disease: a case report
Journal: Rinsho shinkeigaku = Clinical neurology
Published: July 08, 2026
"Et tu, Brute?" -A Case of Ixazomib-Induced Cancer Therapy-Related Cardiac Dysfunction.
Journal: Internal medicine (Tokyo, Japan)
Published: February 23, 2026
Venetoclax and azacitidine therapy in acute myeloid leukemia patients with severe renal impairment.
Journal: American journal of hematology
Published: April 12, 2023
Efficacy and Safety of Synbiotics in Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation: A Randomized, Double-blinded, Placebo-controlled Pilot Study.
Journal: Internal medicine (Tokyo, Japan)
Published: February 15, 2023
Safety and Accuracy of Professional Continuous Glucose Monitoring in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
Journal: Blood cell therapy
Published: December 30, 2022
Where has the lymphoma gone? Pericardial effusion adenosine deaminase may play a key role in diagnosing primary effusion lymphoma-like lymphoma: a case report.
Journal: European heart journal. Case reports
Published: November 14, 2022
Global longitudinal strain is superior to ejection fraction for long-term follow-up after allogeneic hematopoietic stem cell transplantation.
Journal: EJHaem
Published: August 12, 2022
GSK3 inhibitor enhances gemtuzumab ozogamicin-induced apoptosis in primary human leukemia cells by overcoming multiple mechanisms of resistance.
Journal: EJHaem
Published: July 23, 2022
Biclonal Diffuse Large B-cell Lymphoma Commonly Characterized by Partial Trisomy 18q Involving MALT1 and BCL2.
Journal: Internal medicine (Tokyo, Japan)
Published: June 15, 2022
Limited increase in antibody titers following mRNA SARS-CoV-2 vaccination for more than 3 years after final dose of anti-CD20 antibody.
Journal: International journal of hematology
Published: September 06, 2021
Expression of a novel type of KMT2A/EPS15 fusion transcript in FLT3 mutation-positive B-lymphoblastic leukemia with t(1;11)(p32;q23).
Journal: Cancer genetics
Published: April 11, 2020
An mTORC1/2 dual inhibitor, AZD2014, acts as a lysosomal function activator and enhances gemtuzumab ozogamicin-induced apoptosis in primary human leukemia cells.
Journal: International journal of hematology
Published: February 17, 2019
Last Updated: 09/26/2026